EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 25th, 2016 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2016 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated as of May 29, 2015 is made and entered into by and between Synergy Pharmaceuticals Inc., a company incorporated under the laws of the state of Delaware (the “Company”), and Troy M. Hamilton, an individual (the “Executive”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 16th, 2015 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 16th, 2015 Company Industry JurisdictionThis AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated as of July 12, 2013 is made and entered into by and between Synergy Pharmaceuticals, Inc., a company incorporated under the laws of the state of Delaware (the “Company”), and Patrick H. Griffin, M.D., FACP, an individual (the “Executive”).
THIRD AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 16th, 2015 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 16th, 2015 Company Industry JurisdictionThis THIRD AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated as of January 7, 2015 is made and entered into by and between Synergy Pharmaceuticals Inc., a company incorporated under the laws of the state of Delaware (the “Company”), and Kunwar Shailubhai, an individual (the “Executive”).
FOURTH AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 16th, 2015 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 16th, 2015 Company Industry JurisdictionThis FOURTH AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated January 7, 2015 by and between Synergy Pharmaceuticals Inc., a company incorporated under the laws of Delaware (the “Company”), and Gary S. Jacob, Ph.D., an individual (the “Executive”) with reference to the following facts:
SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 3rd, 2014 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 3rd, 2014 Company Industry JurisdictionThis SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated as of March 31, 2014 is made and entered into by and between Synergy Pharmaceuticals Inc., a company incorporated under the laws of the state of Delaware (the “Company”), and Kunwar Shailubhai, an individual (the “Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 18th, 2013 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 18th, 2013 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated December 28, 2012 by and between Synergy Pharmaceuticals Inc., a company incorporated under the laws of Delaware (the “Company”), and Gary S. Jacob, Ph.D., an individual (the “Executive”) with reference to the following facts:
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 9th, 2012 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2012 Company Industry JurisdictionThis AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated as of June 25, 2012 is made and entered into by and between Synergy Pharmaceuticals Inc., a company incorporated under the laws of the state of Delaware (the “Company”), and Kunwar Shailubhai, an individual (the “Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 15th, 2012 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 15th, 2012 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated as of January 20, 2011 is made and entered into by and between Synergy Pharmaceuticals, Inc., a company incorporated under the laws of the state of Florida (the “Company”), and Bernard Denoyer, an individual (the “Executive”).
SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 6th, 2011 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 6th, 2011 Company Industry JurisdictionThis SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated May 2, 2011 by and between Synergy Pharmaceuticals,, Inc., a company incorporated under the laws of Florida (the “Company”), and Gary S. Jacob, Ph.D., an individual (the “Executive”) with reference to the following facts:
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 5th, 2010 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 5th, 2010 Company Industry JurisdictionThis AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated February 1, 2010 by and between Synergy Pharmaceuticals,, Inc., a company incorporated under the laws of Florida (the “Company”), and Gary S. Jacob, Ph.D., an individual (the “Executive”) with reference to the following facts:
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 15th, 2009 • Synergy Pharmaceuticals, Inc. • Retail-retail stores, nec • New York
Contract Type FiledApril 15th, 2009 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated March 11, 2009 by and between Synergy Pharmaceuticals,, Inc., a company incorporated under the laws of Florida (the “Company”), and Gary S. Jacob, Ph.D., an individual (the “Executive”) with reference to the following facts:
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 15th, 2009 • Callisto Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 15th, 2009 Company Industry JurisdictionThis AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated March 11, 2009 by and between Callisto Pharmaceuticals,, Inc., a company incorporated under the laws of Delaware (the “Company”), and Gary S. Jacob, Ph.D., an individual (the “Executive”) with reference to the following facts: